0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

RESULTS OF PROPYLTHIOURACIL THERAPY FOR HYPERTHYROIDISM

E. Perry McCullagh, M.D.; D. C. Humphrey, M.D.; C. J. McGarvey, M.D.; V. Sundgren, M.D.
JAMA. 1951;147(2):106-110. doi:10.1001/jama.1951.03670190006002.
Text Size: A A A
Published online

This article is based on a study of patients treated for hyperthyroidism with propylthiouracil and is concerned chiefly with the ability of such treatment to produce remissions. It also deals with certain advantages and disadvantages related to the over-all clinical handling of the disease by this method. The final decision as to the permanency of remissions would imply following each patient throughout his life. The patients discussed here have almost all been followed for 24 months or less.

The patients studied started treatment between January, 1946, and April, 1947. A total of 179 such hyperthyroid patients were followed. During the same interval of time, 71 additional patients were treated with propylthiouracil, but they could not be included in this survey for various reasons; they were patients who were undergoing trial therapy of arterial hypertension; patients with angina pectoris or congestive failure without hyperthyroidism, and patients who were observed only once

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

1 Views
0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
×
brightcove.createExperiences();